1 Introduction to Research & Analysis Reports
1.1 Parenteral Nutrition Medicament Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parenteral Nutrition Medicament Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parenteral Nutrition Medicament Overall Market Size
2.1 Global Parenteral Nutrition Medicament Market Size: 2022 VS 2029
2.2 Global Parenteral Nutrition Medicament Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Parenteral Nutrition Medicament Sales: 2018-2029
3 Company Landscape
3.1 Top Parenteral Nutrition Medicament Players in Global Market
3.2 Top Global Parenteral Nutrition Medicament Companies Ranked by Revenue
3.3 Global Parenteral Nutrition Medicament Revenue by Companies
3.4 Global Parenteral Nutrition Medicament Sales by Companies
3.5 Global Parenteral Nutrition Medicament Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Parenteral Nutrition Medicament Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Parenteral Nutrition Medicament Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parenteral Nutrition Medicament Players in Global Market
3.8.1 List of Global Tier 1 Parenteral Nutrition Medicament Companies
3.8.2 List of Global Tier 2 and Tier 3 Parenteral Nutrition Medicament Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Parenteral Nutrition Medicament Market Size Markets, 2022 & 2029
4.1.2 Heat
4.1.3 Amino Acid
4.1.4 Vitamins
4.2 By Type – Global Parenteral Nutrition Medicament Revenue & Forecasts
4.2.1 By Type – Global Parenteral Nutrition Medicament Revenue, 2018-2023
4.2.2 By Type – Global Parenteral Nutrition Medicament Revenue, 2024-2029
4.2.3 By Type – Global Parenteral Nutrition Medicament Revenue Market Share, 2018-2029
4.3 By Type – Global Parenteral Nutrition Medicament Sales & Forecasts
4.3.1 By Type – Global Parenteral Nutrition Medicament Sales, 2018-2023
4.3.2 By Type – Global Parenteral Nutrition Medicament Sales, 2024-2029
4.3.3 By Type – Global Parenteral Nutrition Medicament Sales Market Share, 2018-2029
4.4 By Type – Global Parenteral Nutrition Medicament Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Parenteral Nutrition Medicament Market Size, 2022 & 2029
5.1.2 max. 100ml
5.1.3 250ml
5.1.4 500ml
5.1.5 min. 1L
5.2 By Application – Global Parenteral Nutrition Medicament Revenue & Forecasts
5.2.1 By Application – Global Parenteral Nutrition Medicament Revenue, 2018-2023
5.2.2 By Application – Global Parenteral Nutrition Medicament Revenue, 2024-2029
5.2.3 By Application – Global Parenteral Nutrition Medicament Revenue Market Share, 2018-2029
5.3 By Application – Global Parenteral Nutrition Medicament Sales & Forecasts
5.3.1 By Application – Global Parenteral Nutrition Medicament Sales, 2018-2023
5.3.2 By Application – Global Parenteral Nutrition Medicament Sales, 2024-2029
5.3.3 By Application – Global Parenteral Nutrition Medicament Sales Market Share, 2018-2029
5.4 By Application – Global Parenteral Nutrition Medicament Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Parenteral Nutrition Medicament Market Size, 2022 & 2029
6.2 By Region – Global Parenteral Nutrition Medicament Revenue & Forecasts
6.2.1 By Region – Global Parenteral Nutrition Medicament Revenue, 2018-2023
6.2.2 By Region – Global Parenteral Nutrition Medicament Revenue, 2024-2029
6.2.3 By Region – Global Parenteral Nutrition Medicament Revenue Market Share, 2018-2029
6.3 By Region – Global Parenteral Nutrition Medicament Sales & Forecasts
6.3.1 By Region – Global Parenteral Nutrition Medicament Sales, 2018-2023
6.3.2 By Region – Global Parenteral Nutrition Medicament Sales, 2024-2029
6.3.3 By Region – Global Parenteral Nutrition Medicament Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Parenteral Nutrition Medicament Revenue, 2018-2029
6.4.2 By Country – North America Parenteral Nutrition Medicament Sales, 2018-2029
6.4.3 US Parenteral Nutrition Medicament Market Size, 2018-2029
6.4.4 Canada Parenteral Nutrition Medicament Market Size, 2018-2029
6.4.5 Mexico Parenteral Nutrition Medicament Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Parenteral Nutrition Medicament Revenue, 2018-2029
6.5.2 By Country – Europe Parenteral Nutrition Medicament Sales, 2018-2029
6.5.3 Germany Parenteral Nutrition Medicament Market Size, 2018-2029
6.5.4 France Parenteral Nutrition Medicament Market Size, 2018-2029
6.5.5 U.K. Parenteral Nutrition Medicament Market Size, 2018-2029
6.5.6 Italy Parenteral Nutrition Medicament Market Size, 2018-2029
6.5.7 Russia Parenteral Nutrition Medicament Market Size, 2018-2029
6.5.8 Nordic Countries Parenteral Nutrition Medicament Market Size, 2018-2029
6.5.9 Benelux Parenteral Nutrition Medicament Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Parenteral Nutrition Medicament Revenue, 2018-2029
6.6.2 By Region – Asia Parenteral Nutrition Medicament Sales, 2018-2029
6.6.3 China Parenteral Nutrition Medicament Market Size, 2018-2029
6.6.4 Japan Parenteral Nutrition Medicament Market Size, 2018-2029
6.6.5 South Korea Parenteral Nutrition Medicament Market Size, 2018-2029
6.6.6 Southeast Asia Parenteral Nutrition Medicament Market Size, 2018-2029
6.6.7 India Parenteral Nutrition Medicament Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Parenteral Nutrition Medicament Revenue, 2018-2029
6.7.2 By Country – South America Parenteral Nutrition Medicament Sales, 2018-2029
6.7.3 Brazil Parenteral Nutrition Medicament Market Size, 2018-2029
6.7.4 Argentina Parenteral Nutrition Medicament Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Parenteral Nutrition Medicament Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Parenteral Nutrition Medicament Sales, 2018-2029
6.8.3 Turkey Parenteral Nutrition Medicament Market Size, 2018-2029
6.8.4 Israel Parenteral Nutrition Medicament Market Size, 2018-2029
6.8.5 Saudi Arabia Parenteral Nutrition Medicament Market Size, 2018-2029
6.8.6 UAE Parenteral Nutrition Medicament Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Parenteral Nutrition Medicament Major Product Offerings
7.1.4 Baxter Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.1.5 Baxter Key News & Latest Developments
7.2 B. Braun
7.2.1 B. Braun Company Summary
7.2.2 B. Braun Business Overview
7.2.3 B. Braun Parenteral Nutrition Medicament Major Product Offerings
7.2.4 B. Braun Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.2.5 B. Braun Key News & Latest Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Summary
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Parenteral Nutrition Medicament Major Product Offerings
7.3.4 Fresenius Kabi Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.3.5 Fresenius Kabi Key News & Latest Developments
7.4 Kelun Pharma
7.4.1 Kelun Pharma Company Summary
7.4.2 Kelun Pharma Business Overview
7.4.3 Kelun Pharma Parenteral Nutrition Medicament Major Product Offerings
7.4.4 Kelun Pharma Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.4.5 Kelun Pharma Key News & Latest Developments
7.5 Otsuka Pharmaceutical
7.5.1 Otsuka Pharmaceutical Company Summary
7.5.2 Otsuka Pharmaceutical Business Overview
7.5.3 Otsuka Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.5.4 Otsuka Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.5.5 Otsuka Pharmaceutical Key News & Latest Developments
7.6 JW Pharmaceutical
7.6.1 JW Pharmaceutical Company Summary
7.6.2 JW Pharmaceutical Business Overview
7.6.3 JW Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.6.4 JW Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.6.5 JW Pharmaceutical Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Parenteral Nutrition Medicament Major Product Offerings
7.7.4 Pfizer Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.8.4 Teva Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 Haisco Pharmaceutical Group
7.9.1 Haisco Pharmaceutical Group Company Summary
7.9.2 Haisco Pharmaceutical Group Business Overview
7.9.3 Haisco Pharmaceutical Group Parenteral Nutrition Medicament Major Product Offerings
7.9.4 Haisco Pharmaceutical Group Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.9.5 Haisco Pharmaceutical Group Key News & Latest Developments
7.10 King York
7.10.1 King York Company Summary
7.10.2 King York Business Overview
7.10.3 King York Parenteral Nutrition Medicament Major Product Offerings
7.10.4 King York Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.10.5 King York Key News & Latest Developments
7.11 Cisen
7.11.1 Cisen Company Summary
7.11.2 Cisen Parenteral Nutrition Medicament Business Overview
7.11.3 Cisen Parenteral Nutrition Medicament Major Product Offerings
7.11.4 Cisen Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.11.5 Cisen Key News & Latest Developments
7.12 Lummy
7.12.1 Lummy Company Summary
7.12.2 Lummy Parenteral Nutrition Medicament Business Overview
7.12.3 Lummy Parenteral Nutrition Medicament Major Product Offerings
7.12.4 Lummy Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.12.5 Lummy Key News & Latest Developments
7.13 Grand Life Sciences
7.13.1 Grand Life Sciences Company Summary
7.13.2 Grand Life Sciences Parenteral Nutrition Medicament Business Overview
7.13.3 Grand Life Sciences Parenteral Nutrition Medicament Major Product Offerings
7.13.4 Grand Life Sciences Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.13.5 Grand Life Sciences Key News & Latest Developments
7.14 Medisan
7.14.1 Medisan Company Summary
7.14.2 Medisan Business Overview
7.14.3 Medisan Parenteral Nutrition Medicament Major Product Offerings
7.14.4 Medisan Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.14.5 Medisan Key News & Latest Developments
7.15 BBCA Pharmaceutical
7.15.1 BBCA Pharmaceutical Company Summary
7.15.2 BBCA Pharmaceutical Business Overview
7.15.3 BBCA Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.15.4 BBCA Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.15.5 BBCA Pharmaceutical Key News & Latest Developments
7.16 Biokin Pharmaceutical
7.16.1 Biokin Pharmaceutical Company Summary
7.16.2 Biokin Pharmaceutical Business Overview
7.16.3 Biokin Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.16.4 Biokin Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.16.5 Biokin Pharmaceutical Key News & Latest Developments
7.17 Xi’an Libang Pharmaceutical
7.17.1 Xi’an Libang Pharmaceutical Company Summary
7.17.2 Xi’an Libang Pharmaceutical Business Overview
7.17.3 Xi’an Libang Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.17.4 Xi’an Libang Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.17.5 Xi’an Libang Pharmaceutical Key News & Latest Developments
7.18 Lionco Pharmaceutical
7.18.1 Lionco Pharmaceutical Company Summary
7.18.2 Lionco Pharmaceutical Business Overview
7.18.3 Lionco Pharmaceutical Parenteral Nutrition Medicament Major Product Offerings
7.18.4 Lionco Pharmaceutical Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.18.5 Lionco Pharmaceutical Key News & Latest Developments
7.19 China Meheco Kangli
7.19.1 China Meheco Kangli Company Summary
7.19.2 China Meheco Kangli Business Overview
7.19.3 China Meheco Kangli Parenteral Nutrition Medicament Major Product Offerings
7.19.4 China Meheco Kangli Parenteral Nutrition Medicament Sales and Revenue in Global (2018-2023)
7.19.5 China Meheco Kangli Key News & Latest Developments
8 Global Parenteral Nutrition Medicament Production Capacity, Analysis
8.1 Global Parenteral Nutrition Medicament Production Capacity, 2018-2029
8.2 Parenteral Nutrition Medicament Production Capacity of Key Manufacturers in Global Market
8.3 Global Parenteral Nutrition Medicament Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Parenteral Nutrition Medicament Supply Chain Analysis
10.1 Parenteral Nutrition Medicament Industry Value Chain
10.2 Parenteral Nutrition Medicament Upstream Market
10.3 Parenteral Nutrition Medicament Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parenteral Nutrition Medicament Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の非経口栄養薬剤市場予測2023-2029：熱、アミノ酸、ビタミン |
| 【英語タイトル】Parenteral Nutrition Medicament Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5872 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：116 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の非経口栄養薬剤市場規模と予測を収録しています。・世界の非経口栄養薬剤市場：売上、2018年-2023年、2024年-2029年 ・世界の非経口栄養薬剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の非経口栄養薬剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「熱」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 非経口栄養薬剤のグローバル主要企業は、Baxter、 B. Braun、 Fresenius Kabi、 Kelun Pharma、 Otsuka Pharmaceutical、 JW Pharmaceutical、 Pfizer、 Teva Pharmaceutical、 Haisco Pharmaceutical Group、 King York、 Cisen、 Lummy、 Grand Life Sciences、 Medisan、 BBCA Pharmaceutical、 Biokin Pharmaceutical、 Xi'an Libang Pharmaceutical、 Lionco Pharmaceutical、 China Meheco Kangliなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、非経口栄養薬剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の非経口栄養薬剤市場：タイプ別、2018年-2023年、2024年-2029年 世界の非経口栄養薬剤市場：タイプ別市場シェア、2022年 ・熱、アミノ酸、ビタミン 世界の非経口栄養薬剤市場：用途別、2018年-2023年、2024年-2029年 世界の非経口栄養薬剤市場：用途別市場シェア、2022年 ・最大：100ml、250ml、500ml、1L 世界の非経口栄養薬剤市場：地域・国別、2018年-2023年、2024年-2029年 世界の非経口栄養薬剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における非経口栄養薬剤のグローバル売上、2018年-2023年 ・主要企業における非経口栄養薬剤のグローバル売上シェア、2022年 ・主要企業における非経口栄養薬剤のグローバル販売量、2018年-2023年 ・主要企業における非経口栄養薬剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Baxter、 B. Braun、 Fresenius Kabi、 Kelun Pharma、 Otsuka Pharmaceutical、 JW Pharmaceutical、 Pfizer、 Teva Pharmaceutical、 Haisco Pharmaceutical Group、 King York、 Cisen、 Lummy、 Grand Life Sciences、 Medisan、 BBCA Pharmaceutical、 Biokin Pharmaceutical、 Xi'an Libang Pharmaceutical、 Lionco Pharmaceutical、 China Meheco Kangli ************************************************************* ・調査・分析レポートの概要 非経口栄養薬剤市場の定義 市場セグメント 世界の非経口栄養薬剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の非経口栄養薬剤市場規模 世界の非経口栄養薬剤市場規模：2022年 VS 2029年 世界の非経口栄養薬剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの非経口栄養薬剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の非経口栄養薬剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：熱、アミノ酸、ビタミン 非経口栄養薬剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：最大：100ml、250ml、500ml、1L 非経口栄養薬剤の用途別グローバル売上・予測 ・地域別市場分析 地域別非経口栄養薬剤市場規模 2022年と2029年 地域別非経口栄養薬剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Baxter、 B. Braun、 Fresenius Kabi、 Kelun Pharma、 Otsuka Pharmaceutical、 JW Pharmaceutical、 Pfizer、 Teva Pharmaceutical、 Haisco Pharmaceutical Group、 King York、 Cisen、 Lummy、 Grand Life Sciences、 Medisan、 BBCA Pharmaceutical、 Biokin Pharmaceutical、 Xi'an Libang Pharmaceutical、 Lionco Pharmaceutical、 China Meheco Kangli ... |
This report aims to provide a comprehensive presentation of the global market for Parenteral Nutrition Medicament, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Nutrition Medicament. This report contains market size and forecasts of Parenteral Nutrition Medicament in global, including the following market information:
Global Parenteral Nutrition Medicament Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Parenteral Nutrition Medicament Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Parenteral Nutrition Medicament companies in 2022 (%)
The global Parenteral Nutrition Medicament market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Heat Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Parenteral Nutrition Medicament include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parenteral Nutrition Medicament manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parenteral Nutrition Medicament Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Parenteral Nutrition Medicament Market Segment Percentages, by Type, 2022 (%)
Heat
Amino Acid
Vitamins
Global Parenteral Nutrition Medicament Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Parenteral Nutrition Medicament Market Segment Percentages, by Application, 2022 (%)
max. 100ml
250ml
500ml
min. 1L
Global Parenteral Nutrition Medicament Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Parenteral Nutrition Medicament Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parenteral Nutrition Medicament revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Parenteral Nutrition Medicament revenues share in global market, 2022 (%)
Key companies Parenteral Nutrition Medicament sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Parenteral Nutrition Medicament sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
Outline of Major Chapters:
Chapter 1: Introduces the definition of Parenteral Nutrition Medicament, market overview.
Chapter 2: Global Parenteral Nutrition Medicament market size in revenue and volume.
Chapter 3: Detailed analysis of Parenteral Nutrition Medicament manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parenteral Nutrition Medicament in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Parenteral Nutrition Medicament capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の非経口栄養薬剤市場予測2023-2029：熱、アミノ酸、ビタミン] (コード：MMG23JU5872)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の非経口栄養薬剤市場予測2023-2029：熱、アミノ酸、ビタミン]についてメールでお問い合わせ |
